Heather Gates, PA-C

home / authors / heather-gates-pa-c

Heather Gates, PA-C, is a dermatology physician’s assistant from The Villages, Florida. She currently practices at The Dermatology Institute & Skin Cancer Center.

Articles

Empowerment, Education, and Advocacy for NPs and PAs

Empowerment, Education, and Advocacy for NPs and PAs

Marie Bosslett, Assistant Editor;Heather Gates, PA-C
June 2nd 2025

Heather Gates, PA-C, shares insights on the importance of continuous learning, mentorship, and legislative reform for PAs and NPs in dermatology.

Heather Gates, PA-C, Leads Inaugural Aesthetics Workshop at Fall Clinical PA/NP

Heather Gates, PA-C, Leads Inaugural Aesthetics Workshop at Fall Clinical PA/NP

Marie Bosslett, Assistant Editor;Heather Gates, PA-C
June 1st 2025

Discover the latest advancements in aesthetics as Heather Gates, PA-C, shares innovative techniques and emerging technologies from this groundbreaking workshop.

Practical Strategies for Harnessing AI and Social Media in Dermatology

Practical Strategies for Harnessing AI and Social Media in Dermatology

Marie Bosslett, Assistant Editor;Heather Gates, PA-C
May 30th 2025

In her presentation at Fall Clinical NP/PA, Heather Gates, PA-C, shared how professionals can enhance their practice using AI and social media, fostering authenticity and patient trust in a digital age.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Published: November 17th 2023 | Updated: June 11th 2025
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Barzolvolimab Demonstrates Rapid Symptom Reduction in Chronic Spontaneous Urticaria
Published: June 9th 2025 | Updated: June 11th 2025
Barzolvolimab Demonstrates Rapid Symptom Reduction in Chronic Spontaneous Urticaria
Late-Breaking Data: Lebrikizumab Demonstrates Efficacy in Patients With Skin of Color With AD
Published: June 7th 2025 | Updated: June 11th 2025
Late-Breaking Data: Lebrikizumab Demonstrates Efficacy in Patients With Skin of Color With AD
Evaluating Stress Levels in AD Treatment Plans
Published: November 9th 2023 | Updated: June 11th 2025
Evaluating Stress Levels in AD Treatment Plans
Dupilumab Significantly Enhances Quality of Life and Reduces Cumulative Impairment in Patients with Moderate to Severe Atopic Dermatitis
Published: June 7th 2025 | Updated: June 11th 2025
Dupilumab Significantly Enhances Quality of Life and Reduces Cumulative Impairment in Patients with Moderate to Severe Atopic Dermatitis
© 2025 MJH Life Sciences

All rights reserved.